Literature DB >> 33664882

Regional variation in the use of catheter ablation for patients with arrhythmia in Japan.

Takahiro Inoue1, Hiroyo Kuwabara1.   

Abstract

BACKGROUND: Regional variation in the use of percutaneous coronary intervention (PCI), especially when performed as an elective procedure, was observed in a previous study. The use of a developing technology, catheter ablation (CA), was compared between regions in Japan. METHODS AND
RESULTS: The Diagnostic Procedure Combination data, which are publicly available, were used for the analysis. The number of CAs was summarized and the rates for CA and PCI were calculated based on the prefecture's population aged ≥40 years. A linear regression model was constructed to identify the factors associated with regional variation in the use of CA. The number of CAs performed per hospital consistently increased from 2009 to 2018. The mean rate of CA across Japan was 119 per 100 000 population aged ≥40 years in 2018. The highest CA rate was 166 per 100 000 and the lowest CA rate was 29 per 100 000 in 2018, while the highest and lowest PCI rates for angina per 100 000 were 361 and 88 in 2018, respectively. The significant factor associated with regional variation in the CA rate was the number of specialists.
CONCLUSIONS: A wide regional variation was observed in the use of CA for patients with arrhythmia in Japan. Further research is needed to generate evidence of CA for decision-making as a treatment option and to appropriately deploy this health service regardless of where patients live.
© 2020 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Heart Rhythm Society.

Entities:  

Keywords:  arrhythmia; atrial fibrillation; catheter ablation; regional variation

Year:  2020        PMID: 33664882      PMCID: PMC7896467          DOI: 10.1002/joa3.12455

Source DB:  PubMed          Journal:  J Arrhythm        ISSN: 1880-4276


  15 in total

1.  Forty years of unwarranted variation--and still counting.

Authors:  John E Wennberg
Journal:  Health Policy       Date:  2014-01       Impact factor: 2.980

2.  Investigating Regional Variation of Cardiac Implantable Electrical Device Implant Rates in European Healthcare Systems: What Drives Differences?

Authors:  Aleksandra Torbica; Helen Banks; Cinzia Valzania; Giuseppe Boriani; Giovanni Fattore
Journal:  Health Econ       Date:  2017-02       Impact factor: 3.046

3.  Small area variations in health care delivery.

Authors:  J Wennberg
Journal:  Science       Date:  1973-12-14       Impact factor: 47.728

4.  Regional Variation in Utilization, In-hospital Mortality, and Health-Care Resource Use of Transcatheter Aortic Valve Implantation in the United States.

Authors:  Tanush Gupta; Ankur Kalra; Dhaval Kolte; Sahil Khera; Pedro A Villablanca; Kashish Goel; Anna E Bortnick; Wilbert S Aronow; Julio A Panza; Neal S Kleiman; J Dawn Abbott; David P Slovut; Cynthia C Taub; Gregg C Fonarow; Michael J Reardon; Charanjit S Rihal; Mario J Garcia; Deepak L Bhatt
Journal:  Am J Cardiol       Date:  2017-08-10       Impact factor: 2.778

5.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

Authors:  Oussama M Wazni; Nassir F Marrouche; David O Martin; Atul Verma; Mandeep Bhargava; Walid Saliba; Dianna Bash; Robert Schweikert; Johannes Brachmann; Jens Gunther; Klaus Gutleben; Ennio Pisano; Dominico Potenza; Raffaele Fanelli; Antonio Raviele; Sakis Themistoclakis; Antonio Rossillo; Aldo Bonso; Andrea Natale
Journal:  JAMA       Date:  2005-06-01       Impact factor: 56.272

6.  The association between local diagnostic testing intensity and invasive cardiac procedures.

Authors:  D E Wennberg; M A Kellett; J D Dickens; D J Malenka; L M Keilson; R B Keller
Journal:  JAMA       Date:  1996-04-17       Impact factor: 56.272

7.  Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project.

Authors:  G T O'Connor; H B Quinton; N D Traven; L D Ramunno; T A Dodds; T A Marciniak; J E Wennberg
Journal:  JAMA       Date:  1999-02-17       Impact factor: 56.272

8.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.

Authors:  Carlos A Morillo; Atul Verma; Stuart J Connolly; Karl H Kuck; Girish M Nair; Jean Champagne; Laurence D Sterns; Heather Beresh; Jeffrey S Healey; Andrea Natale
Journal:  JAMA       Date:  2014-02-19       Impact factor: 56.272

9.  Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination.

Authors:  Hiroshi Inoue; Akira Fujiki; Hideki Origasa; Satoshi Ogawa; Ken Okumura; Isao Kubota; Yoshifusa Aizawa; Takeshi Yamashita; Hirotsugu Atarashi; Minoru Horie; Tohru Ohe; Yoshinori Doi; Akihiko Shimizu; Akiko Chishaki; Tetsunori Saikawa; Katsusuke Yano; Akira Kitabatake; Hideo Mitamura; Itsuo Kodama; Shiro Kamakura
Journal:  Int J Cardiol       Date:  2008-08-08       Impact factor: 4.164

10.  Differences in per capita rates of revascularization and in choice of revascularization procedure for eleven states.

Authors:  Edward L Hannan; Chuntao Wu; Mark R Chassin
Journal:  BMC Health Serv Res       Date:  2006-03-16       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.